Please login to the form below

Not currently logged in

emerging markets

This page shows the latest emerging markets news and features for those working in and with pharma, biotech and healthcare.

PMEA 2020: continuing to recognise excellence in improving patient outcomes

PMEA 2020: continuing to recognise excellence in improving patient outcomes

3, Excellence in Collaboration and Partnerships. Sponsored by Sanofi Genzyme. Winner: AstraZeneca Emerging Markets Health Innovation Hubs: Reimagining Patient Experiences and Improving Health Outcomes Through Unique Collaborations by AstraZeneca.

Latest news

More from news
Approximately 13 fully matching, plus 354 partially matching documents found.

Latest Intelligence

  • Pharma funding and M&A in 2020 Pharma funding and M&A in 2020

    As we see with Takeda – and as we’ve seen with other industries, notably tech – companies from fast- growing emerging markets continue to rise.

  • BRIC markets BRIC markets

    The idea was to illustrate the growing importance of emerging economies relative to developed markets and to encourage the G7 to factor them into policymaking. ... He added: “The hype about BRIC markets is cooler than it used to be.

  • The mission matters The mission matters

    Developed and emerging markets differ greatly but there are also great differences between developed markets, such as Europe and the US. ... And within markets, therapy areas differ hugely, ranging from rare diseases and oncology to primary care and

  • Leading AstraZeneca’s return to growth in Europe Leading AstraZeneca’s return to growth in Europe

    Now the business has two particularly strong growth drivers: emerging markets, most especially China, and oncology, where a triumvirate of drugs – Tagrisso, Imfinzi and Lynparza – have hit a major growth phase. ... So does AstraZeneca believe there

  • It’s not the end of the world, is it? It’s not the end of the world, is it?

    the US market when they would, de facto, be barred from other developed and price-controlled markets. ... As emerging markets become richer, access to at least basic healthcare is one of the first developed market characteristics that their citizens seek

More from intelligence
Approximately 14 fully matching, plus 61 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 35 partially matching documents found.

Latest from PMHub

  • Live webinar

    China: How pharma can maximize success in this rapidly changing emerging market. ... Register for this live webinar in which Research Partnership's emerging market experts explore the recent 2020 healthcare reforms, digital transformations as a result of

  • Syndicated study

    Maximising digital communications with physicians in China. Research Partnership are currently conducting a syndicated study to assess the impact of COVID-19 on how Chinese doctors use digital channels to interact with pharma companies through

  • Article: Spotlight on Mexico

    Healthcare under AMLO – One year on. In this article, Rachel Howard and local expert Dr Xavier Tello, discuss the latest changes in the healthcare system and consider what they mean for pharmaceutical manufacturers wishing to enter the Mexican

  • News: Mandira Kar joins London Headquarters as Qualitative Research Director

    She has previously worked in a wide range of research industries including consumer and digital and has experience in many global markets, especially emerging markets, having lived and worked for a

  • Article: Market access in Brazil

    All eyes on Spinraza. Director Rachel Howard asks, “What does Brazil’s unprecedented risk-sharing agreement in Spinal Muscular Atrophy (SMA) mean for the future of market access in Brazil? In April 2019, Brazilian Health Minister Luiz Henrique

More from PMHub
Approximately 68 fully matching, plus 39 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...